Insiders Denali Therapeutics Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 20:54:23 26/06/2024 BST			5-day change	1st Jan Change
21.97 ^USD	-1.88%		+1.82%	+1.54%

06-13	Pliant Therapeutics, Inc. Appoints Steve Krognes to Its Board of Directors and Chairperson of Audit Committee	CI
06-03	Denali Therapeutics' Enzyme Replacement Therapy Picked for FDA's START Pilot Program; Shares Rise	MT

Pliant Therapeutics, Inc. Appoints Steve Krognes to Its Board of Directors and Chairperson of Audit Committee	06-13	CI
Denali Therapeutics Insider Sold Shares Worth $1,896,250, According to a Recent SEC Filing	04-03	MT
Denali Therapeutics Insider Sold Shares Worth $402,420, According to a Recent SEC Filing	02-16	MT
Insider Sell: Denali Therapeutics	19/07/23	MT
Insider Sell: Denali Therapeutics	17/05/23	MT
Insider Sell: Denali Therapeutics	16/02/23	MT
Insider Sell: Denali Therapeutics	14/02/23	MT
Insider Sell: Denali Therapeutics	03/11/22	MT
Insider Sell: Denali Therapeutics	30/09/22	MT
Denali Therapeutics COO to Add CFO Duties; Current CFO to Join Board	15/03/22	MT
Denali Therapeutics Inc. Appoints Steve Krognes to Board of Directors	15/03/22	CI
Denali Therapeutics Announces Appointment of Erik Harris to Board of Directors	07/02/22	CI
Insider Sell: Denali Therapeutics	03/11/21	MT
Insider Sell: Denali Therapeutics	05/10/21	MT
Denali Therapeutics Inc Appoints Katie Peng as Chief Commercial Officer	27/09/21	CI
Insider Sell: Denali Therapeutics	09/09/21	MT
Insider Sell: Denali Therapeutics	03/09/21	MT
Insider Trends: Denali Therapeutics Insider Continues 90-Day Selling Trend	06/08/21	MT
Insider Trends: Denali Therapeutics Insider Extends 90-Day Selling Trend	05/08/21	MT
Insider Trends: Denali Therapeutics Insider Extends 90-Day Selling Trend	23/07/21	MT

No results for this search